Cargando…

Anticancer and antimicrobial properties of novel η(6)-p-cymene ruthenium(ii) complexes containing a N,S-type ligand, their structural and theoretical characterization

Ruthenium(ii) complexes are lately of great scientific interest due to their chemotherapeutic potential as anticancer and antimicrobial agents. Here we present the synthesis of new pyrazole carbothioamide derivatives and their four arene–ruthenium complexes. The title compounds were characterized wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namiecińska, Ewelina, Sadowska, Beata, Więckowska-Szakiel, Marzena, Dołęga, Anna, Pasternak, Beata, Grazul, Magdalena, Budzisz, Elzbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2019
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075995/ https://www.ncbi.nlm.nih.gov/pubmed/35540189 http://dx.doi.org/10.1039/c9ra08736b

Ejemplares similares

Arene-Ruthenium(II) Complexes with Carbothiamidopyrazoles as a Potential Alternative for Antibiotic Resistance in Human
por: Namiecińska, Ewelina, et al.
Publicado: (2022)

Physicochemical Studies and Anticancer Potency of Ruthenium η(6)-p-Cymene Complexes Containing Antibacterial Quinolones
por: Kljun, Jakob, et al.
Publicado: (2011)

Mechanistic Studies of Arene–Ruthenium(II) Complexes with Carbothioamidopyrazoles as Alternative Cancer Drugs
por: Hikisz, Paweł, et al.
Publicado: (2023)

Dichlorido(η(6)-p-cymene)(ethoxydiphenylphosphane)ruthenium(II)
por: Knapp, Spring M. M., et al.
Publicado: (2012)

Dichlorido(η(6)-p-cymene)(4-fluoroaniline-κN)ruthenium(II)
por: Sykora, Richard E., et al.
Publicado: (2010)

(η(6)-p-Cymene)bis(trichloridostannyl)(triethoxyphosphine-κP)ruthenium(II)
por: Shapovalov, Sergey S., et al.
Publicado: (2009)

The Immunomodulatory Activity of Staphylococcus aureus Products Derived from Biofilm and Planktonic Cultures
por: Sadowska, Beata, et al.
Publicado: (2013)

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
por: Adhireksan, Zenita, et al.
Publicado: (2014)

DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (Poly)cyclic Aromatic Diamine Ligands
por: Alsaeedi, Mona S., et al.
Publicado: (2020)

Dichlorido(η(6)-p-cymene)[tris(4-methoxyphenyl)phosphane]ruthenium(II)
por: Davis, Wade L., et al.
Publicado: (2021)

Crystal structure of [3-amino-2-(phenyldiazenyl)pyridine]chlorido(η(6)-p-cymene)ruthenium(II) chloride
por: Hansongnern, Kanidtha, et al.
Publicado: (2015)

p-Cymene Complexes of Ruthenium(II) as Antitumor Agents
por: Pujante-Galián, María Angeles, et al.
Publicado: (2020)

μ-Pyrazine-2,5-dicarboxylato-bis[chlorido(η(6)-p-cymene)ruthenium(II)] tert-butanol disolvate
por: Sanchez Ballester, Noelia M., et al.
Publicado: (2008)

Antiadherent and Antibiofilm Activity of Humulus lupulus L. Derived Products: New Pharmacological Properties
por: Rozalski, Marcin, et al.
Publicado: (2013)

Phenolic and Nonpolar Fractions of Elaeagnus rhamnoides (L.) A. Nelson Extracts as Virulence Modulators—In Vitro Study on Bacteria, Fungi, and Epithelial Cells
por: Różalska, Barbara, et al.
Publicado: (2018)

Bioactivity Studies on Titania Coatings and the Estimation of Their Usefulness in the Modification of Implant Surfaces
por: Radtke, Aleksandra, et al.
Publicado: (2017)

Molecular Mechanisms of Leonurus Cardiaca L. Extract Activity in Prevention of Staphylococcal Endocarditis—Study on in Vitro and ex Vivo Models
por: Sadowska, Beata, et al.
Publicado: (2019)

Tetraethylammonium trichlorido(η(6)-p-cymene)ruthenate(II)
por: Wu, Fang-Hui, et al.
Publicado: (2009)

Facile Arene Ligand Exchange in p-Cymene Ruthenium(II) Complexes of Tertiary P-Chiral Ferrocenyl Phosphines
por: Popp, John, et al.
Publicado: (2019)

Saponins of Trifolium spp. Aerial Parts as Modulators of Candida Albicans Virulence Attributes
por: Budzyńska, Aleksandra, et al.
Publicado: (2014)

Phenolic and Non-Polar Fractions of the Extracts from Fruits, Leaves, and Twigs of Elaeagnus rhamnoides (L.) A. Nelson—The Implications for Human Barrier Cells
por: Sadowska, Beata, et al.
Publicado: (2020)

The Bioactivity and Photocatalytic Properties of Titania Nanotube Coatings Produced with the Use of the Low-Potential Anodization of Ti6Al4V Alloy Surface
por: Radtke, Aleksandra, et al.
Publicado: (2017)

Optimization of the Silver Nanoparticles PEALD Process on the Surface of 1-D Titania Coatings
por: Radtke, Aleksandra, et al.
Publicado: (2017)

(2,2′-Bipyridyl)(η(6)-p-cymene)iodidoruthenium(II) hexafluoridophosphate
por: Kelani, Monsuru T., et al.
Publicado: (2023)

(η(6)-p-Cymene)(1,3-dimesityl-2,3-dihydro-1H-imidazol-2-ylidene)bis(pentafluorobenzoato-κO)ruthenium(II) dichloromethane disolvate
por: Dorst, Konstantin, et al.
Publicado: (2012)

Titania Nanotubes/Hydroxyapatite Nanocomposites Produced with the Use of the Atomic Layer Deposition Technique: Estimation of Bioactivity and Nanomechanical Properties
por: Radtke, Aleksandra, et al.
Publicado: (2019)

[(1R)-3-Benzoyl-1,7,7-trimethylbicyclo[2.2.1]heptan-2-onato-κ(2) O,O′]chlorido(η(6)-p-cymene)ruthenium(II)
por: Harrad, Mohamed Anouar, et al.
Publicado: (2010)

Combination of ruthenium(II)-arene complex [Ru(η(6)-p-cymene)Cl(2)(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity
por: Berndsen, Robert H., et al.
Publicado: (2017)

Crystal structures of (E)-3-(4-hydroxybenzylidene)chroman-4-one and (E)-3-(3-hydroxybenzylidene)-2-phenylchroman-4-one
por: Suchojad, Kamil, et al.
Publicado: (2019)

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer
por: Domínguez-Jurado, Elena, et al.
Publicado: (2021)

Synthesis, Characterization, and Cytotoxicity Studies of N-(4-Methoxybenzyl) Thiosemicarbazone Derivatives and Their Ruthenium(II)-p-cymene Complexes
por: Martínez-Estévez, Mónica, et al.
Publicado: (2022)

NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells
por: Garufi, Alessia, et al.
Publicado: (2023)

(η(5)-Cyclopentadienyl)(η(6)-mesitylamine)ruthenium(II) hexafluoridophosphate
por: Becker, Eva, et al.
Publicado: (2009)

1,3-Bis(2-thienylmethyl)-4,5-dihydroimidazolium trichlorido(η(6)-p-cymene)ruthenate(II)
por: Arslan, Hakan, et al.
Publicado: (2009)

(R,R (Fc),S (Ru))-Chlorido(η(6)-p-cymene){1-[1-(diphenylphosphanyl)ethyl]-2-[2-(diphenylphosphanyl)phenyl]ferrocene-κ(2) P,P′}ruthenium(II) hexafluoridophosphate
por: Schuecker, Raffael, et al.
Publicado: (2011)

Synthesis, crystal structure and catalytic activity in reductive amination of dichlorido(η(6)-p-cymene)(2′-dicyclohexylphosphanyl-2,6-dimethoxybiphenyl-κP)ruthenium(II)
por: Makarova, Maria, et al.
Publicado: (2018)

Benzoyldicarbonyl(η(5)-indenyl)ruthenium(II)
por: Oudenhoven, Tracey A., et al.
Publicado: (2010)

Dichlorido(dimethyl sulfoxide-κS)(η(6)-mesitylene)ruthenium(II)
por: Oelkers, Benjamin, et al.
Publicado: (2011)

(η(5)-Pentamethylcyclopentadienyl)(η(6)-toluene)ruthenium(II) hexafluoridophosphate
por: O, Wylie W. N., et al.
Publicado: (2010)

(η(6)-Benzophenone)(η(5)-pentamethylcyclopentadienyl)ruthenium(II) tetraphenylborate
por: Loughrey, Bradley T., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_92dgqbq9vtrt3vfkb768gbfl5s